Lantheus closes SPECT business sale to SHINE Technologies

Este artículo fue publicado originalmente aquí

Lantheus (LNTH) Holdings completed the previously announced sale of its single photon emission computed tomography business to SHINE Technologies. Under the terms of the agreement, SHINE has acquired Lantheus’ SPECT business, including its diagnostic agents, the portion of the North Billerica, Massachusetts campus that manufactures Lantheus’ SPECT products, and the SPECT-related Canadian operations. With the SPECT divestiture finalized, Lantheus will focus on its growing commercial portfolio of PET radiodiagnostics and microbubbles, while also advancing its pipeline of radiopharmaceuticals.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. >;elm:context_link;itc:0;sec:content-canvas” class=”link “>Try Now>>

>;elm:context_link;itc:0;sec:content-canvas” class=”link “>See Insiders’ Hot Stocks on TipRanks >>

Read More on LNTH:

Disclaimer & DisclosureReport an Issue